The Auditory Naming Test Improves Diagnosis of Naming Deficits in Dementia

Joseph A. Hirsch, George M. Cuesta, Barry D. Jordan, Pasquale Fonzetti, Leann Levin

Research output: Contribution to journalArticle

Abstract

Many patients with presumptive Alzheimer’s disease (AD) or other dementias may show minimal impairment on the Boston Naming Test (BNT), a visual confrontation naming measure. We sought to determine whether a semantic naming test, the Auditory Naming Test (ANT), would improve accuracy for identifying naming deficits in patients diagnosed with dementia (N = 458) at an outpatient memory disorders clinic. Factor analysis revealed that both tests measured the same broad construct. Frequency of naming impairment with the ANT was significantly greater than with the BNT for patients with AD, regardless of dementia severity or levels of education (p <.01). Effect size was moderate (φ = 0.45). BNT but not ANT performance declined with age in patients with AD. Sex differences were found for the BNT, but not the ANT, in the AD population. Accuracy rate of naming impairment diagnosis with the ANT in patients with AD was good (72%). Specificity (81%) and positive predictive value (PPV) (89%) with the ANT in AD were excellent, whereas sensitivity (69%) and negative predictive value (NPV) (58%) were modest. Receiver operating characteristic with area under the curve (ROC AUC) was excellent (0.958). A similar pattern was seen in patients with vascular dementia (VaD) or mixed AD/VaD. There was no significant effect in patients with amnestic mild cognitive impairment (aMCI). It is concluded that the ANT substantially improves the ability to diagnose naming impairment in patients with AD, VaD, and mixed AD/VaD dementia, and should be included in a neuropsychological battery administered to elderly patients with suspected dementia.

Original languageEnglish (US)
JournalSAGE Open
Volume6
Issue number3
DOIs
StatePublished - Aug 1 2016
Externally publishedYes

Fingerprint

dementia
deficit
Naming
Hearing
Dementia
Alzheimer's Disease
level of education

Keywords

  • Alzheimer’s disease
  • anomia
  • assessment of cognitive disorders/dementia
  • naming
  • neuropsychology

ASJC Scopus subject areas

  • Arts and Humanities(all)
  • Social Sciences(all)

Cite this

The Auditory Naming Test Improves Diagnosis of Naming Deficits in Dementia. / Hirsch, Joseph A.; Cuesta, George M.; Jordan, Barry D.; Fonzetti, Pasquale; Levin, Leann.

In: SAGE Open, Vol. 6, No. 3, 01.08.2016.

Research output: Contribution to journalArticle

Hirsch, Joseph A. ; Cuesta, George M. ; Jordan, Barry D. ; Fonzetti, Pasquale ; Levin, Leann. / The Auditory Naming Test Improves Diagnosis of Naming Deficits in Dementia. In: SAGE Open. 2016 ; Vol. 6, No. 3.
@article{7763f7cc04334543bf0a4d463f36ca17,
title = "The Auditory Naming Test Improves Diagnosis of Naming Deficits in Dementia",
abstract = "Many patients with presumptive Alzheimer’s disease (AD) or other dementias may show minimal impairment on the Boston Naming Test (BNT), a visual confrontation naming measure. We sought to determine whether a semantic naming test, the Auditory Naming Test (ANT), would improve accuracy for identifying naming deficits in patients diagnosed with dementia (N = 458) at an outpatient memory disorders clinic. Factor analysis revealed that both tests measured the same broad construct. Frequency of naming impairment with the ANT was significantly greater than with the BNT for patients with AD, regardless of dementia severity or levels of education (p <.01). Effect size was moderate (φ = 0.45). BNT but not ANT performance declined with age in patients with AD. Sex differences were found for the BNT, but not the ANT, in the AD population. Accuracy rate of naming impairment diagnosis with the ANT in patients with AD was good (72{\%}). Specificity (81{\%}) and positive predictive value (PPV) (89{\%}) with the ANT in AD were excellent, whereas sensitivity (69{\%}) and negative predictive value (NPV) (58{\%}) were modest. Receiver operating characteristic with area under the curve (ROC AUC) was excellent (0.958). A similar pattern was seen in patients with vascular dementia (VaD) or mixed AD/VaD. There was no significant effect in patients with amnestic mild cognitive impairment (aMCI). It is concluded that the ANT substantially improves the ability to diagnose naming impairment in patients with AD, VaD, and mixed AD/VaD dementia, and should be included in a neuropsychological battery administered to elderly patients with suspected dementia.",
keywords = "Alzheimer’s disease, anomia, assessment of cognitive disorders/dementia, naming, neuropsychology",
author = "Hirsch, {Joseph A.} and Cuesta, {George M.} and Jordan, {Barry D.} and Pasquale Fonzetti and Leann Levin",
year = "2016",
month = "8",
day = "1",
doi = "10.1177/2158244016665693",
language = "English (US)",
volume = "6",
journal = "SAGE Open",
issn = "2158-2440",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - The Auditory Naming Test Improves Diagnosis of Naming Deficits in Dementia

AU - Hirsch, Joseph A.

AU - Cuesta, George M.

AU - Jordan, Barry D.

AU - Fonzetti, Pasquale

AU - Levin, Leann

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Many patients with presumptive Alzheimer’s disease (AD) or other dementias may show minimal impairment on the Boston Naming Test (BNT), a visual confrontation naming measure. We sought to determine whether a semantic naming test, the Auditory Naming Test (ANT), would improve accuracy for identifying naming deficits in patients diagnosed with dementia (N = 458) at an outpatient memory disorders clinic. Factor analysis revealed that both tests measured the same broad construct. Frequency of naming impairment with the ANT was significantly greater than with the BNT for patients with AD, regardless of dementia severity or levels of education (p <.01). Effect size was moderate (φ = 0.45). BNT but not ANT performance declined with age in patients with AD. Sex differences were found for the BNT, but not the ANT, in the AD population. Accuracy rate of naming impairment diagnosis with the ANT in patients with AD was good (72%). Specificity (81%) and positive predictive value (PPV) (89%) with the ANT in AD were excellent, whereas sensitivity (69%) and negative predictive value (NPV) (58%) were modest. Receiver operating characteristic with area under the curve (ROC AUC) was excellent (0.958). A similar pattern was seen in patients with vascular dementia (VaD) or mixed AD/VaD. There was no significant effect in patients with amnestic mild cognitive impairment (aMCI). It is concluded that the ANT substantially improves the ability to diagnose naming impairment in patients with AD, VaD, and mixed AD/VaD dementia, and should be included in a neuropsychological battery administered to elderly patients with suspected dementia.

AB - Many patients with presumptive Alzheimer’s disease (AD) or other dementias may show minimal impairment on the Boston Naming Test (BNT), a visual confrontation naming measure. We sought to determine whether a semantic naming test, the Auditory Naming Test (ANT), would improve accuracy for identifying naming deficits in patients diagnosed with dementia (N = 458) at an outpatient memory disorders clinic. Factor analysis revealed that both tests measured the same broad construct. Frequency of naming impairment with the ANT was significantly greater than with the BNT for patients with AD, regardless of dementia severity or levels of education (p <.01). Effect size was moderate (φ = 0.45). BNT but not ANT performance declined with age in patients with AD. Sex differences were found for the BNT, but not the ANT, in the AD population. Accuracy rate of naming impairment diagnosis with the ANT in patients with AD was good (72%). Specificity (81%) and positive predictive value (PPV) (89%) with the ANT in AD were excellent, whereas sensitivity (69%) and negative predictive value (NPV) (58%) were modest. Receiver operating characteristic with area under the curve (ROC AUC) was excellent (0.958). A similar pattern was seen in patients with vascular dementia (VaD) or mixed AD/VaD. There was no significant effect in patients with amnestic mild cognitive impairment (aMCI). It is concluded that the ANT substantially improves the ability to diagnose naming impairment in patients with AD, VaD, and mixed AD/VaD dementia, and should be included in a neuropsychological battery administered to elderly patients with suspected dementia.

KW - Alzheimer’s disease

KW - anomia

KW - assessment of cognitive disorders/dementia

KW - naming

KW - neuropsychology

UR - http://www.scopus.com/inward/record.url?scp=84989339187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989339187&partnerID=8YFLogxK

U2 - 10.1177/2158244016665693

DO - 10.1177/2158244016665693

M3 - Article

AN - SCOPUS:84989339187

VL - 6

JO - SAGE Open

JF - SAGE Open

SN - 2158-2440

IS - 3

ER -